RASSFIA interacts with microtubule-associated proteins and modulates microtubule dynamics

被引:117
|
作者
Dallol, A
Agathanggelou, A
Fenton, SL
Ahmed-Choudhury, J
Hesson, L
Vos, MD
Clark, GJ
Downward, J
Maher, ER
Latif, F [1 ]
机构
[1] Univ Birmingham, Sect Med & Mol Genet, Div Reprod & Child Hlth, Sch Med, Birmingham B15 2TT, W Midlands, England
[2] Natl Canc Inst, Dept Cell & Canc Biol, Rockville, MD USA
[3] Canc Res UK, Signal Transduct Lab, London Res Inst, London, England
[4] Univ Birmingham, Sch Med, Canc Res UK, Renal Mol Oncol Res Grp, Birmingham, W Midlands, England
关键词
D O I
10.1158/0008-5472.CAN-04-0267
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The candidate tumor suppressor gene RASSF1A is inactivated in many types of adult and childhood cancers. However, the mechanisms by which RASSF1A exerts its tumor suppressive functions have yet to be elucidated. To this end, we performed a yeast two-hybrid screen to identify novel RASSF1A-interacting proteins in a human brain cDNA library. Seventy percent of interacting clones bad homology to microtubule-associated proteins, including MAP1B and VCY2IP1/C19ORF5. RASSF1A association with MAP1B and VCY2IP1/C19ORF5 was subsequently confirmed in mammalian cell lines. This suggested that RASSF1A may exert its tumor-suppressive functions through interaction with the microtubules. We demonstrate that RASSF1A associates with the microtubules, causing them to exist as hyperstabilized circular bundles. We found that two naturally occurring tumor-associated missense substitutions in the RASSF1A coding region, C65R and R257Q, perturb the association of RASSF1A with the microtubules. The C65R and R257Q in addition to VCY2IP1/C19ORF5 showed reduced ability to induce microtubule acetylation and were unable to protect the microtubules against the depolymerizing action of nocodazole. In addition, wild-type RASSF1A but not the C65R or the R257Q is able to block DNA synthesis. Our data identify a role for RASSF1A in the regulation of microtubules and cell cycle dynamics that could be part of the mechanism(s) by which RASSF1A exerts its growth inhibition on cancer cells.
引用
收藏
页码:4112 / 4116
页数:5
相关论文
共 50 条
  • [41] THE INTERACTION OF ACTIN AND MICROTUBULE-ASSOCIATED PROTEINS
    PRUS, K
    SHANBHAG, V
    BACKMAN, L
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1982, : 64 - 64
  • [42] MICROTUBULE-ASSOCIATED PROTEINS AND NEURONAL MORPHOGENESIS
    MATUS, A
    [J]. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1988, 9 (01) : 97 - 97
  • [43] Mammalian oocyte maturation and microtubule-associated proteins dynamics.
    Rawe, VY
    Español, AJ
    Nodar, F
    Olmedo, SB
    [J]. FERTILITY AND STERILITY, 2005, 84 : S143 - S143
  • [44] Modulation of Microtubule Dynamics by the Microtubule-Associated Protein 1a
    Faller, Elliott M.
    Brown, David L.
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (05) : 1080 - 1089
  • [45] The MAPI family of microtubule-associated proteins
    Halpain, Shelley
    Dehmelt, Leif
    [J]. GENOME BIOLOGY, 2006, 7 (06)
  • [46] MICROTUBULE-ASSOCIATED PROTEINS - SUBUNITS OF THE CYTOMATRIX
    VALLEE, RB
    BLOOM, GS
    THEURKAUF, WE
    [J]. JOURNAL OF CELL BIOLOGY, 1984, 99 (01): : S38 - S44
  • [47] Arc interacts with microtubules/microtubule-associated protein 2 and attenuates microtubule-associated protein 2 immunoreactivity in the dendrites
    Fujimoto, T
    Tanaka, H
    Kumamaru, E
    Okamura, K
    Miki, N
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 76 (01) : 51 - 63
  • [48] Effect of aluminium on the phosphorylation of microtubule-associated brain proteins and microtubule assembly
    Burbaeva, G
    Shevtsov, P
    Boksha, I
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S496 - S497
  • [49] EVIDENCE FOR ACTIN FILAMENT MICROTUBULE INTERACTION MEDIATED BY MICROTUBULE-ASSOCIATED PROTEINS
    GRIFFITH, LM
    POLLARD, TD
    [J]. JOURNAL OF CELL BIOLOGY, 1978, 78 (03): : 958 - 965
  • [50] EFFECTS OF MICROTUBULE-ASSOCIATED PROTEINS ON MICROTUBULE ASSEMBLY AND THE PROTEIN-PHOSPHORYLATION
    YAMAMOTO, H
    FUKUNAGA, K
    TANAKA, E
    MIYAMOTO, E
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P350 - P350